221 related articles for article (PubMed ID: 33783349)
1. Calibration of the WHO 5th IS for Blood Coagulation Factor IX, Concentrate and Ph. Eur. Human Coagulation Factor IX Concentrate Biological Reference Preparation Batch 3 and investigation of the suitability of an IS as potency standard for purified full-length recombinant FIX.
Gray E; Hogwood J; Dougall T; Rigsby P; Matejtschuk P; Terao E
Pharmeur Bio Sci Notes; 2021; 2021():26-68. PubMed ID: 33783349
[TBL] [Abstract][Full Text] [Related]
2. Collaborative study for the establishment of replacement batches for human coagulation factor IX concentrate reference standards.
Gray E; Pickering W; Hockley J; Rigsby P; Weinstein M; Terao E; Buchheit KH
Pharmeuropa Bio; 2008 Dec; 2008(1):19-30. PubMed ID: 19220978
[TBL] [Abstract][Full Text] [Related]
3. Recombinant factor IX: discrepancies between one-stage clotting and chromogenic assays.
Wilmot HV; Hogwood J; Gray E
Haemophilia; 2014 Nov; 20(6):891-7. PubMed ID: 24800651
[TBL] [Abstract][Full Text] [Related]
4. Calibration of human coagulation factor VIII concentrate Ph. Eur. BRP Batch 4 for use in potency assays.
Raut S; Costanzo A; Daniels S; Heath A; Buchheit KH
Pharmeur Bio Sci Notes; 2010 Oct; 2010(2):1-29. PubMed ID: 21144486
[TBL] [Abstract][Full Text] [Related]
5. Calibration of human coagulation factor VII concentrate Ph. Eur. BRP batch 2.
Dodt J; Costanzo A; Daas A; Hunfeld A; Buchheit KH
Pharmeur Bio Sci Notes; 2010 Apr; 2010(1):31-8. PubMed ID: 20223188
[TBL] [Abstract][Full Text] [Related]
6. Calibration of the Ph. Eur. Biological Reference Preparation (BRP) for tetanus vaccine (adsorbed) batch 3.
Tierney R; Hockley J; Rigsby P; Terao E; Daas A; Buchheit KH; Sesardic D
Pharmeur Bio Sci Notes; 2011 Jun; 2011(1):1-26. PubMed ID: 21619853
[TBL] [Abstract][Full Text] [Related]
7. Calibration of the Ph. Eur. human coagulation Factor VIII Concentrate BRP batch 6.
Raut S; Le Tallec D; Costanzo A
Pharmeur Bio Sci Notes; 2021; 2021():88-100. PubMed ID: 33973517
[TBL] [Abstract][Full Text] [Related]
8. Establishment of the human coagulation factor VII concentrate European Pharmacopoeia biological reference preparation batch 1.
Dodt J; Hunfeld A; Daas A; Buchheit KH
Pharmeuropa Bio; 2006 Nov; 2006(1):15-22. PubMed ID: 17270128
[TBL] [Abstract][Full Text] [Related]
9. Performance of a recombinant fusion protein linking coagulation factor IX with recombinant albumin in one-stage clotting assays.
Horn C; Négrier C; Kalina U; Seifert W; Friedman KD
J Thromb Haemost; 2019 Jan; 17(1):138-148. PubMed ID: 30418692
[TBL] [Abstract][Full Text] [Related]
10. Calibration of the Ph. Eur. BRP Batch 3/Mega 2 (US/FDA) standard for human coagulation factor VIII concentrate for use in the potency assay.
Kirschbaum N; Wood L; Lachenbruch P; Weinstein M; Daas A; Rautmann G; Spieser JM; Buchheit KH
Pharmeuropa Spec Issue Biol; 2002 Jun; 2002(1):31-64. PubMed ID: 12448031
[TBL] [Abstract][Full Text] [Related]
11. Potency estimates for recombinant factor IX in the one-stage clotting assay are influenced by more than just the choice of activated partial thromboplastin time reagent.
Wilmot HV; Gray E
Haemophilia; 2018 Sep; 24(5):e363-e368. PubMed ID: 30051554
[TBL] [Abstract][Full Text] [Related]
12. Measuring factor IX activity of nonacog beta pegol with commercially available one-stage clotting and chromogenic assay kits: a two-center study.
Bowyer AE; Hillarp A; Ezban M; Persson P; Kitchen S
J Thromb Haemost; 2016 Jul; 14(7):1428-35. PubMed ID: 27107268
[TBL] [Abstract][Full Text] [Related]
13. Calibration of the Ph. Eur. human coagulation Factor VIII concentrate BRP batch 5.
Raut S; Costanzo A; Daas A; Buchheit KH
Pharmeur Bio Sci Notes; 2017; 2017():1-11. PubMed ID: 28279252
[TBL] [Abstract][Full Text] [Related]
14. Calibration of European pharmacopoeia biological reference preparation for diphtheria vaccine (adsorbed) batch 4.
Stickings P; Rigsby P; Buchheit KH; Sesardic D
Pharmeur Bio Sci Notes; 2009 Oct; 2009(1):1-9. PubMed ID: 20144448
[TBL] [Abstract][Full Text] [Related]
15. Comparative field study: impact of laboratory assay variability on the assessment of recombinant factor IX Fc fusion protein (rFIXFc) activity.
Sommer JM; Buyue Y; Bardan S; Peters RT; Jiang H; Kamphaus GD; Gray E; Pierce GF
Thromb Haemost; 2014 Nov; 112(5):932-40. PubMed ID: 25144892
[TBL] [Abstract][Full Text] [Related]
16. Potency determination of factor VIII and factor IX for new product labelling and postinfusion testing: challenges for caregivers and regulators.
Dodt J; Hubbard AR; Wicks SJ; Gray E; Neugebauer B; Charton E; Silvester G
Haemophilia; 2015 Jul; 21(4):543-9. PubMed ID: 25623631
[TBL] [Abstract][Full Text] [Related]
17. Activity measurements of dalcinonacog alfa.
Williams SC; Gray E
Haemophilia; 2020 Mar; 26(2):346-353. PubMed ID: 32142203
[TBL] [Abstract][Full Text] [Related]
18. Collaborative study for the establishment of the WHO 3(rd) International Standard for Endotoxin, the Ph. Eur. endotoxin biological reference preparation batch 5 and the USP Reference Standard for Endotoxin Lot H0K354.
Findlay L; Desai T; Heath A; Poole S; Crivellone M; Hauck W; Ambrose M; Morris T; Daas A; Rautmann G; Buchheit KH; Spieser JM; Terao E
Pharmeur Bio Sci Notes; 2015; 2015():73-98. PubMed ID: 26830160
[TBL] [Abstract][Full Text] [Related]
19. Calibration of the 7th British Working Standard for factors II, IX and X, concentrate.
Roberts G; Wilmot H; Dougall T; Rigsby P; Gray E
Biologicals; 2018 Nov; 56():63-66. PubMed ID: 30146418
[TBL] [Abstract][Full Text] [Related]
20. A collaborative study to establish the 7th International Standard for Factor VIII Concentrate.
Raut S; Bevan S; Hubbard AR; Sands D; Barrowcliffe TW
J Thromb Haemost; 2005 Jan; 3(1):119-26. PubMed ID: 15634275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]